(IBHH) iShares iBonds 2028 Term - Ratings and Ratios
High-Yield Bonds, Corporate Bonds, USD-Denominated, Fixed-Rate, 2028 Maturity
Dividends
| Dividend Yield | 5.92% |
| Yield on Cost 5y | 7.24% |
| Yield CAGR 5y | 16.92% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 2.70% |
| Value at Risk 5%th | 4.44% |
| Relative Tail Risk | -0.11% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.68 |
| Alpha | 1.61 |
| CAGR/Max DD | 1.94 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.146 |
| Beta | 0.203 |
| Beta Downside | 0.290 |
| Drawdowns 3y | |
|---|---|
| Max DD | 4.73% |
| Mean DD | 0.70% |
| Median DD | 0.38% |
Description: IBHH iShares iBonds 2028 Term January 01, 2026
The iShares iBonds 2028 Term High Yield and Income ETF (BATS: IBHH) tracks an index of U.S.-dollar-denominated, taxable, fixed-rate corporate bonds that are rated high-yield or BBB and that all mature between 1 Jan 2028 and 15 Dec 2028. The fund may include non-U.S. issuers when required to replicate the index, and it is classified as a non-diversified, target-maturity ETF.
Key metrics to watch: the fund’s weighted-average yield is currently around 6.2%, reflecting the elevated compensation investors demand for credit risk; its effective duration is roughly 4.5 years, indicating moderate sensitivity to interest-rate moves; and the average spread over Treasuries sits near 350 bps, a level that tends to widen sharply during recessionary periods. Primary economic drivers include the Federal Reserve’s policy stance (which influences both rates and high-yield spreads) and corporate default rates, while sector concentration is tilted toward energy and industrials, which together account for roughly 30 % of assets.
For a deeper quantitative comparison, you may want to explore ValueRay’s analytics platform.
What is the price of IBHH shares?
Over the past week, the price has changed by +0.13%, over one month by +0.82%, over three months by +1.22% and over the past year by +8.02%.
Is IBHH a buy, sell or hold?
What are the forecasts/targets for the IBHH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 26.9 | 13.5% |
IBHH Fundamental Data Overview December 25, 2025
Beta = 0.65
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 388.8m USD (388.8m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 388.8m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 388.8m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.76% (E(388.8m)/V(388.8m) * Re(6.76%) + (debt-free company))
Discount Rate = 6.76% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for IBHH ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle